Intravitreal Injection of Anti-VEGF Antibody Induces Glomerular Endothelial Cells Injury

INTRODUCTION: Antiangiogenic agents that inhibit vascular endothelial growth factor have emerged as important tools in cancer therapy and ocular diseases. Their systemic use can induce renal limited microangiopathy. Local use of anti-VEGF agent is supposed to be safe. We report here a unique case of...

Descripción completa

Detalles Bibliográficos
Autores principales: Touzani, F., Geers, C., Pozdzik, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942715/
https://www.ncbi.nlm.nih.gov/pubmed/31934470
http://dx.doi.org/10.1155/2019/2919080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942715/
https://www.ncbi.nlm.nih.gov/pubmed/31934470
http://dx.doi.org/10.1155/2019/2919080

Ejemplares similares